An update from GlaxoSmithKline ( (GB:GSK) ) is now available.
GSK has announced the repurchase of 547,800 of its ordinary shares as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. This move is part of a strategic effort to manage its capital structure and enhance shareholder value, with the shares being held in treasury. The company now holds a total of 174,109,205 shares in treasury, with 4,141,068,225 shares in issue, excluding treasury shares, impacting the total number of voting rights available to shareholders.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a leading global healthcare company operating in the pharmaceutical industry. It focuses on the development and manufacturing of medicines, vaccines, and consumer healthcare products.
YTD Price Performance: 10.14%
Average Trading Volume: 7,985,177
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £59.81B
Find detailed analytics on GSK stock on TipRanks’ Stock Analysis page.